ImmunoGen_0802: Ph 1b/2 IMGN632
Clinical Trial Grant
Awarded By
ImmunoGen, Inc.
Start Date
January 14, 2020
End Date
January 14, 2026
Awarded By
ImmunoGen, Inc.
Start Date
January 14, 2020
End Date
January 14, 2026